Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
about
Oncogenic potential of mouse translation elongation factor-1 delta, a novel cadmium-responsive proto-oncogeneGuanine nucleotides regulate sphingosine kinase 1 activation by eukaryotic elongation factor 1A and provide a mechanism for eEF1A-associated oncogenesisTranslationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1ASuppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancerIdentification and temporal expression pattern of genes modulated during irreversible growth arrest and terminal differentiation in human melanoma cells.Prostate-tumor-inducing gene-1 analysis in human prostate cancer cells and tissue in relation to Mycoplasma infection.Blocking the translation elongation factor-1 delta with its antisense mRNA results in a significant reversal of its oncogenic potential.Molecular markers and determinants of prostate cancer metastasis.Understanding cancer metastasis: an urgent need for using differential gene expression analysis.Clinical significance of elongation factor-1 delta mRNA expression in oesophageal carcinoma.Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer.An eEF1A1 truncation encoded by PTI-1 exerts its oncogenic effect inside the nucleus.C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A.Networking of differentially expressed genes in human cancer cells resistant to methotrexate.The role of translation elongation factor eEF1A in intracellular alkalinization-induced tumor cell growth.
P2860
Q23919609-C9F1C821-F32B-4DB1-9EB1-E023F05FB015Q24299680-2185F310-DBA0-41A4-8CB9-185911A8CD36Q24631271-7364B6EC-EC87-43E9-B821-EA780E3D7D03Q28279309-347A6C1B-D06D-4012-8FD4-EC666FB31E67Q30641951-B73D5141-CC28-48AC-96AB-AB6554A27E07Q33375781-C600CACC-EA0A-40A7-8955-0B1069739399Q34147636-53AE72B7-63F9-48A5-A7B0-04A685AE4C63Q34465689-475CCE86-0969-40A7-B681-315086F240E9Q34580473-09E389C2-D36A-4D6C-82FF-96189DEEA43CQ36695285-0A1D2AEF-A197-476D-8E1D-80E8EC842CEBQ37930972-61332823-DBD4-4991-B509-CAA9CA7EF8B0Q39020748-F3E9BB0C-EFF3-4AB6-BBE4-F95C191280A7Q40164334-BB91C097-716C-4B72-B0AD-F9DB80C5E8A7Q42594754-9CCCCDC5-580F-4E9D-8B3E-220694C98A04Q42798447-DA5FDD5A-2A0E-40CA-A7A9-0CFC21A12091
P2860
Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
@ast
Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
@en
type
label
Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
@ast
Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
@en
prefLabel
Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
@ast
Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
@en
P2093
P2860
P356
P1476
Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes.
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.4.1764
P407
P577
1998-02-01T00:00:00Z